GGrantIndex
← Leaderboards

Steven G Coca

Yale University

$6,183,329
Attributed
$9,049,495
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $995.5K · FY200725
$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,041,505 · 7

By mechanism

R01$5,128,214 · 2
U01$2,897,284 · 2
U2C$992,010 · 1
K23$957,215 · 1
F32$66,782 · 1

Most similar at Yale University

Same institution · by research overlap

Others in their field

Top investigators on “Kidney

Research focus

KidneyChronic Kidney FailureCohortFollow-UpGlomerular Filtration RateDialysis ProcedurePathway InteractionsMorbidity - Disease RateFutureUrineInjurySample SizeProteinsKidney DiseasesSamplingEnrollmentEnd Stage Renal FailureDiabetes MellitusDiabetic NephropathyAcuteCreatinineBloodBiological MarkersCessation Of Life

Grant awards (25)

New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$522,111
U2C · FY2025 · DK
Mount Sinai Health System Kidney Precision Medicine Project$374,999
U01 · FY2025 · DK · contact PI
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$469,899
U2C · FY2024 · DK
Mount Sinai Health System Kidney Precision Medicine Project$399,999
U01 · FY2024 · DK · contact PI
Mount Sinai Health System Kidney Precision Medicine Project$425,000
U01 · FY2023 · DK
Mount Sinai Health System Kidney Precision Medicine Project$374,867
U01 · FY2022 · DK
Impact of Exercise on Kidney Function and Injury among Elders in the LIFE Trial$691,041
R01 · FY2020 · DK
Impact of Exercise on Kidney Function and Injury among Elders in the LIFE Trial$711,643
R01 · FY2019 · DK
Leveraging Clinical Trials of Diabetic Kidney Disease to Advance Biomarkers$225,913
U01 · FY2019 · DK
Impact of Exercise on Kidney Function and Injury among Elders in the LIFE Trial$778,243
R01 · FY2018 · DK
Leveraging Clinical Trials of Diabetic Kidney Disease to Advance Biomarkers$200,000
U01 · FY2018 · DK
Leveraging Clinical Trials of Diabetic Kidney Disease to Advance Biomarkers$1
U01 · FY2017 · DK
Novel serum and urinary biomarkers of diabetic kidney disease$494,759
R01 · FY2016 · DK · contact PI
Leveraging Clinical Trials of Diabetic Kidney Disease to Advance Biomarkers$446,508
U01 · FY2016 · DK
Novel serum and urinary biomarkers of diabetic kidney disease$545,522
R01 · FY2015 · DK · contact PI
Leveraging Clinical Trials of Diabetic Kidney Disease to Advance Biomarkers$449,997
U01 · FY2015 · DK
Novel serum and urinary biomarkers of diabetic kidney disease$617,764
R01 · FY2014 · DK · contact PI
Novel serum and urinary biomarkers of diabetic kidney disease$631,452
R01 · FY2013 · DK · contact PI
Novel serum and urinary biomarkers of diabetic kidney disease$657,790
R01 · FY2012 · DK · contact PI
Long-term Prognosis of Acute Kidney Injury in Cardiac Surgery$194,206
K23 · FY2012 · DK · contact PI
Long-term Prognosis of Acute Kidney Injury in Cardiac Surgery$195,286
K23 · FY2011 · DK · contact PI
Long-term Prognosis of Acute Kidney Injury in Cardiac Surgery$193,398
K23 · FY2010 · DK · contact PI
Long-term Prognosis of Acute Kidney Injury in Cardiac Surgery$189,102
K23 · FY2009 · DK · contact PI
Long-term Prognosis of Acute Kidney Injury in Cardiac Surgery$185,223
K23 · FY2008 · DK · contact PI
Urinary Biomarkers for Acute Kidney Injury in Critical Illness$66,782
F32 · FY2007 · DK · contact PI